<DOC>
	<DOC>NCT00573521</DOC>
	<brief_summary>This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.</brief_summary>
	<brief_title>Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms</brief_title>
	<detailed_description>This is chart review at UPMC. NO human subject interaction will occur.</detailed_description>
	<mesh_term>Enterobacteriaceae Infections</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin, tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<criteria>Clinical information is collected by chart review of "case" and "control" patients. A "case A" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam resistant. A "case B" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam susceptible. Additionally, 1 control patient in the hospital at the same time as the case patients will be randomly selected for each case and are not in either case group. Patients &lt; 18 years of age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ESBL positive cultures</keyword>
</DOC>